Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-peptidase-4”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Study completedNCT02273050
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,136
Testing effectiveness (Phase 2)Study completedNCT02127047
What this trial is testing

Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1
University Hospital, Basel, Switzerland 24
Post-approval studies (Phase 4)UnknownNCT02802644
What this trial is testing

The Effect of DPP4 Inhibitor on Vasclular Healing

Who this might be right for
Acute Coronary SyndromeDiabetes Mellitus, Type 2
Chung-Ang University 66
Post-approval studies (Phase 4)Study completedNCT02941445
What this trial is testing

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Who this might be right for
Polycystic Ovary SyndromeBody Weight
University Medical Centre Ljubljana 24
Post-approval studies (Phase 4)Study completedNCT02330406
What this trial is testing

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Who this might be right for
Dipeptidyl-Peptidase 4 InhibitorsLDL CholesterolGlycosylated Hemoglobin+2 more
Institute for Clinical Effectiveness, Japan 353
Not applicableStudy completedNCT02849691
What this trial is testing

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

Who this might be right for
Dipeptidyl-peptidase-4STEMIPCI+2 more
Chinese PLA General Hospital 747
Early research (Phase 1)Study completedNCT02009488
What this trial is testing

Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 59
Not applicableStudy completedNCT01272583
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Who this might be right for
Type 1 DiabetesHypoglycemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 16
Post-approval studies (Phase 4)Ended earlyNCT02653131
What this trial is testing

The Use of DPP-4 Inhibitors in Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Stanley Dudrick's Memorial Hospital 8
Testing effectiveness (Phase 2)Study completedNCT02803892
What this trial is testing

Monotherapy With Rapamycin in Long-standing Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Piemonti Lorenzo 55
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Large-scale testing (Phase 3)Study completedNCT00676338
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 820
Not applicableUnknownNCT01642108
What this trial is testing

Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Niigata Medical Center 40
Large-scale testing (Phase 3)Study completedNCT01922817
What this trial is testing

DPP4inhibitors in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycaemia
University of Dundee 28
Testing effectiveness (Phase 2)Ended earlyNCT00947011
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Who this might be right for
Glucose Homeostasis
Johns Hopkins University 12
Large-scale testing (Phase 3)Study completedNCT01242228
What this trial is testing

Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 106
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Post-approval studies (Phase 4)UnknownNCT03499704
What this trial is testing

Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Celltrion Pharm, Inc. 133
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Post-approval studies (Phase 4)Looking for participantsNCT06399835
What this trial is testing

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 120
Load More Results